Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1J2 Inhibitors

OR1J2 inhibitors are a class of chemical compounds that specifically target and modulate the activity of the olfactory receptor OR1J2, a member of the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR1J2 are primarily involved in the detection of odorant molecules and the initiation of signal transduction pathways that result in the perception of smell. OR1J2 belongs to a larger family of olfactory receptors, which are encoded by a vast gene family and exhibit a highly diverse sequence to recognize a wide array of volatile compounds. Inhibitors of OR1J2 can act by binding to the receptor in a way that prevents the activation of downstream signaling pathways, thereby modulating the receptor's ability to respond to odorant molecules. This interaction is primarily non-covalent, involving hydrogen bonding, van der Waals forces, and occasionally π-π interactions with aromatic residues within the binding pocket of OR1J2.

The structural basis for the design of OR1J2 inhibitors relies heavily on the identification of key motifs within the receptor that are responsible for ligand binding and activation. Molecular modeling and in silico docking studies have provided insight into the conformational changes that occur upon inhibitor binding. These inhibitors often possess a high degree of structural specificity, as minor alterations in their chemical structure can lead to significant changes in binding affinity and selectivity. Additionally, OR1J2 inhibitors are valuable for exploring the functional role of this receptor in olfactory signaling and its broader involvement in chemosensory pathways. By modulating OR1J2 activity, researchers can gain a deeper understanding of the molecular mechanisms underlying odorant recognition and signal transduction, which has implications for the study of GPCR biology and the complexity of olfactory systems in general.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

Blocks calcium channels potentially involved in OR1J2 signaling pathways.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Chelates intracellular calcium, which may be crucial for OR1J2 signaling.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Inactivates G-proteins that could be coupled to OR1J2, thus inhibiting downstream signaling.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that can modulate kinase-dependent OR1J2 signaling cascades.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

Potent Gs-alpha subunit inhibitor, possibly affecting OR1J2-mediated pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, which may play a role in OR1J2-mediated signaling processes.

PD 168393

194423-15-9sc-222138
1 mg
$162.00
4
(1)

Irreversible inhibitor of EGFR tyrosine kinase, impacting pathways OR1J2 may engage.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$138.00
$220.00
$972.00
47
(2)

Inhibits protein kinase A, which could be involved in OR1J2 signal transduction.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

Inhibits myosin light chain kinase, affecting cytoskeletal changes linked to OR1J2 activation.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Non-selective protein kinase inhibitor that may disrupt OR1J2-associated signaling.